Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an ...
Expects to Submit Conditional Marketing Approval Application in Europe for Iopofosine I 131 in Refractory (post-BTKi) ...
Our productive engagement with the European Medicines Agency (EMA) highlighted by confirmation of eligibility to submit for a conditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback